ESSA Announces Filing of Second Amended and Restated Prospectus Supplement and an Update to Previously Announced Equity Offering

January 5, 2018

Responsive image

HOUSTON and VANCOUVER, Jan. 5, 2018 /PRNewswire/ – ESSA Pharma Inc. (TSXV: EPI; NASDAQ: EPIX) (“ESSA” or the “Company”) announces a further update to its previously announced equity offering. As previously announced, the Company intends to issue up to 125,000,000 common shares of the Compa…

Category: Precious Metals